Literature DB >> 21497458

Cognitive recovery during and after treatment for volatile solvent abuse.

Kylie M Dingwall1, Paul Maruff, Amy Fredrickson, Sheree Cairney.   

Abstract

BACKGROUND: Cognitive impairment reflecting CNS disruption in chronic solvent abusers can resolve within two years of abstinence. However, the specific time course for recovery has yet to be determined empirically. This study monitored cognition among solvent (i.e., gasoline) abusers throughout 8 weeks of residential treatment. It also investigated the extent to which solvent-related cognitive impairments persisted following discharge.
METHODS: Non-drug using healthy controls (n=33) and solvent abusers (n=29) who had inhaled gasoline, regularly or episodically, for an average of 4.3 years (SD=2.7) were assessed. Using linear mixed model analyses, solvent abusers were compared to healthy controls throughout treatment at baseline, two weeks, four weeks and six weeks, on visual motor, attention, learning, memory, and executive function tasks. Ten users who maintained abstinence were reassessed an average of 12 months later (SD=2.8) and were compared to healthy controls (n=12) retested at the same time interval using ANCOVA while controlling for age and baseline performance.
RESULTS: At baseline, solvent abusers showed cognitive deficits on visual motor, learning and memory, paired associate learning, and executive functions. Paired associate learning performance improved within 6 weeks of abstinence, however, impairments in visual motor speed, learning and memory, and executive function persisted throughout and in some cases beyond treatment.
CONCLUSIONS: Cognitive deficits exist for solvent abusers upon treatment entry. Some impairments resolve within weeks of abstinence, while memory and executive function improves gradually over months to years of abstinence, and might never fully recover.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497458     DOI: 10.1016/j.drugalcdep.2011.03.017

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  10 in total

1.  Interventions for inhalant abuse among First Nations youth.

Authors:  Justin Xg Zhu; Michael Rieder
Journal:  Paediatr Child Health       Date:  2012-08       Impact factor: 2.253

2.  Cyclohexane Inhalation Produces Long-Lasting Alterations in the Hippocampal Integrity and Reward-Seeking Behavior in the Adult Mouse.

Authors:  Tania Campos-Ordonez; David Zarate-Lopez; Nereida Ibarra-Castaneda; Jonathan Buritica; Oscar Gonzalez-Perez
Journal:  Cell Mol Neurobiol       Date:  2019-02-15       Impact factor: 5.046

Review 3.  Volatile solvents as drugs of abuse: focus on the cortico-mesolimbic circuitry.

Authors:  Jacob T Beckley; John J Woodward
Journal:  Neuropsychopharmacology       Date:  2013-08-19       Impact factor: 7.853

4.  Specific impairments in instrumental learning following chronic intermittent toluene inhalation in adolescent rats.

Authors:  Alec L W Dick; Martin Axelsson; Andrew J Lawrence; Jhodie R Duncan
Journal:  Psychopharmacology (Berl)       Date:  2013-12-10       Impact factor: 4.530

5.  Effects of acute and chronic inhalation of paint thinner in mice: behavioral and immunohistochemical study.

Authors:  Karim Fifel; Mohamed Bennis; Saâdia Ba-M'hamed
Journal:  Metab Brain Dis       Date:  2013-11-12       Impact factor: 3.584

6.  The Abused Inhalant Toluene Impairs Medial Prefrontal Cortex Activity and Risk/Reward Decision-Making during a Probabilistic Discounting Task.

Authors:  Kevin M Braunscheidel; Michael P Okas; Michaela Hoffman; Patrick J Mulholland; Stan B Floresco; John J Woodward
Journal:  J Neurosci       Date:  2019-09-23       Impact factor: 6.167

7.  Adolescent toluene inhalation in rats affects white matter maturation with the potential for recovery following abstinence.

Authors:  Jhodie Rubina Duncan; Alec Lindsay Ward Dick; Gary Egan; Scott Kolbe; Maria Gavrilescu; David Wright; Dan Ian Lubman; Andrew John Lawrence
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

8.  Spontaneous dense array gamma activity in children and adolescents with volatile solvent dependence.

Authors:  Sai Krishna Tikka; Nizamuddin Parvez; Arvind Nongpiur; Nishant Goyal; Vinod Kumar Sinha
Journal:  J Pediatr Neurosci       Date:  2014 Sep-Dec

9.  What is the optimum thiamine dose to treat or prevent Wernicke's encephalopathy or Wernicke-Korsakoff syndrome? Results of a randomized controlled trial.

Authors:  Kylie M Dingwall; Jennifer F Delima; Paula Binks; Robert Batey; Stephen C Bowden
Journal:  Alcohol Clin Exp Res       Date:  2022-05-10       Impact factor: 3.928

10.  Exploring the reliability and acceptability of cognitive tests for Indigenous Australians: a pilot study.

Authors:  Kylie M Dingwall; Allison O Gray; Annette R McCarthy; Jennifer F Delima; Stephen C Bowden
Journal:  BMC Psychol       Date:  2017-08-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.